Allurion Technologies Inc. (ALUR)

USD 0.31

(-1.65%)

Net Income Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual net income in 2023 was -82.3 Million USD , down -118.06% from previous year.
  • Allurion Technologies Inc.'s latest quarterly net income in 2024 Q1 was 5.58 Million USD , up 129.12% from previous quarter.
  • Allurion Technologies Inc. reported an annual net income of -37.74 Million USD in 2022, down -204.73% from previous year.
  • Allurion Technologies Inc. reported an annual net income of -12.38 Million USD in 2021, down -239520.82% from previous year.
  • Allurion Technologies Inc. reported a quarterly net income of -2.16 Million USD for 2024 Q2, down -138.7% from previous quarter.
  • Allurion Technologies Inc. reported a quarterly net income of -21.63 Million USD for 2023 Q3, up 1.66% from previous quarter.

Annual Net Income Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Net Income of Allurion Technologies Inc. (2023 - 2020)

Year Net Income Net Income Growth
2023 -82.3 Million USD -118.06%
2022 -37.74 Million USD -204.73%
2021 -12.38 Million USD -239520.82%
2020 -5169.00 USD 0.0%

Peer Net Income Comparison of Allurion Technologies Inc.

Name Net Income Net Income Difference
Abbott Laboratories 5.72 Billion USD 101.438%
Artivion, Inc. -30.69 Million USD -168.179%
Avanos Medical, Inc. -61.8 Million USD -33.178%
Butterfly Network, Inc. -133.69 Million USD 38.441%
Butterfly Network, Inc. -133.69 Million USD 38.441%
Bio-Rad Laboratories, Inc. -637.32 Million USD 87.086%
Boston Scientific Corporation 1.59 Billion USD 105.167%
Perspective Therapeutics, Inc. -14.67 Million USD -461.036%
CONMED Corporation 64.45 Million USD 227.684%
Edwards Lifesciences Corporation 1.4 Billion USD 105.869%
Paragon 28, Inc. -47.84 Million USD -72.037%
Glaukos Corporation -134.66 Million USD 38.881%
Globus Medical, Inc. 122.87 Million USD 166.983%
Inspire Medical Systems, Inc. -21.15 Million USD -289.089%
Integer Holdings Corporation 90.65 Million USD 190.793%
Medtronic plc 3.67 Billion USD 102.239%
Nevro Corp. -92.21 Million USD 10.746%
Owlet, Inc. -32.9 Million USD -150.157%
Penumbra, Inc. 90.95 Million USD 190.49%
Vicarious Surgical Inc. -71.07 Million USD -15.805%
Smith & Nephew plc 263 Million USD 131.294%
Sonendo, Inc. -60.91 Million USD -35.104%
STERIS plc 378.23 Million USD 121.76%
Stryker Corporation 3.16 Billion USD 102.6%
Vapotherm, Inc. -58.19 Million USD -41.433%
Zimmer Biomet Holdings, Inc. 1.02 Billion USD 108.038%